kruisproeven

Kruisproeven, often referred to in English as cross-over trials, are a type of randomized controlled trial design used in clinical and biomedical research. In a kruisproef, each participant receives multiple interventions in a predefined sequence, with a washout period between treatments to minimize carryover effects. Because participants experience more than one treatment, they can be compared within the same individual, which increases statistical efficiency and often reduces the required sample size.

Typical designs include two-period AB/BA studies, where participants are randomly assigned to receive treatment A followed by B or B followed by A, as well as more complex multi-period sequences such as ABAC or Latin square designs. Randomization of the treatment sequence and, when possible, blinding of participants and investigators help reduce bias. A critical consideration is the washout period; it should be long enough to ensure that the effects of the first treatment do not influence the outcomes of the second.

Kruisproeven offer advantages such as heightened power to detect treatment differences and explicit within-subject comparisons. They are particularly suitable for chronic conditions with stable outcomes and when the treatment effect is reversible. However, they are not appropriate for conditions that change over time, for interventions with lasting or irreversible effects, or when high dropout rates could bias within-subject comparisons. Carryover effects and period effects must be assessed and addressed in the analysis, which often uses paired analyses, mixed-effects models, or dedicated cross-over models. An intention-to-treat approach is common, with sensitivity analyses to explore potential carryover or period-related biases.